English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 30 May 2019, 16:16 JST
Share:
    

Source: Hitachi, Ltd.
Hitachi Signs Contract with HIMED Xuzhou City, Jiangsu Province, China to Deliver Particle Therapy System

TOKYO, May 30, 2019 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501) has signed a contract with Himed Hospital Management (Xuzhou) Co., Ltd., located in Xuzhou City, Jiangsu Province, People's Republic of China, on May 29 to deliver particle therapy system with capability of irradiating both proton and heavy ion. This is the first order for Hitachi's overseas project of multi ion particle therapy system. With its capability of generating both proton and heavy ion in one accelerator, the system can realize flexible treatment according to various symptom of patients and tumor sites.

The contract signing ceremony

The system will equip one 360-degree rotating gantry room for proton therapy and three fixed beam rooms for carbon therapy, as well as features including real time image gating motion management to irradiate the targeted tumor while in motion and advanced scanning technology to irradiate even tumors with complex shapes with high precision. A treatment planning software, also included in the scope of contract, will utilize imaging data and calculate the appropriate dose to prepare the most suitable, patient-specific treatment plans for each patient. The system will be installed at comprehensive particle therapy center in Xuzhou city, which Himed starts building construction within this year.

The number of site for particle therapy in China is expected to increase in the future, and multiple particle therapy sites are being built in China.

Hitachi has been proactively promoting particle therapy system business worldwide, supplying world-class facilities around the world with its highly reliable and proven particle therapy systems, which have treated more than 60,000 patients.

Hitachi will continue to accelerate the globalization of its particle therapy system business and contribute to cancer treatment around the world.

Overview of Particle Therapy

Particle Therapy is an advanced type of cancer radiotherapy. Protons extracted from hydrogen atoms, or carbon ions are accelerated up to 70% of the speed of light. This energy is concentrated directly on the tumor while minimizing radiation dose to surrounding healthy tissue. Particle therapy improves the quality of life for cancer patients since the patient experiences no pain during treatment and the procedure has very few side effects compared to that of traditional radiotherapy. In most cases, patients can continue with their normal daily activities while undergoing treatment.

Contact:
Hitachi Ltd
Corporate Communications
Tel: +81-3-3258-1111


Topic: Press release summary
Source: Hitachi, Ltd.

Sectors: BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2022 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 
Hitachi, Ltd. Links

http://www.hitachi.com

https://www.facebook.com/hitachi.global/

https://twitter.com/hitachiglobal?lang=en

https://www.youtube.com/user/HitachiBrandChannel

https://ph.linkedin.com/company/hitachi

Hitachi, Ltd. Releated News
2022年9月28日 13時00分 JST
日立、金融機関のDXを加速し、非対面・非来店取引を促進するネット×リアルチャネルソリューション「Branch in Mobile」を提供開始
2022年9月27日 14時30分 JST
栗田工業と日立、製鉄所などの原料ヤード管理のDXに向け協創開始
Monday, 26 September 2022, 20:25 JST
Hitachi Astemo Receives EV e-Axle Orders from Honda, and will Further Expand its Electrification Business
2022年9月22日 14時00分 JST
日立、浪江町において民生・産業向け水素利用サプライチェーン構築およびデジタル技術で電力需給調整を行う実証事業に参画
2022年9月22日 14時00分 JST
日立エナジーが、冷却システムを一体化した鉄道向け乾式牽引用変圧器を発売
More news >>
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575